Search

everythinglearnresearchcommunity

for

Search:↓

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Linagliptin may cause hair loss and skin blisters.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Linagliptin slows down premature aging in certain mice.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Antibiotics often cause skin reactions, making them a major health concern.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Juniperus plants contain compounds with potential for developing various medical treatments.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Pranlukast and mirabegron may work as new diabetes drugs.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Fat stem cells from diabetic mice can still help heal wounds.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Effective PCOS treatments require targeting specific signaling pathways.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Testosterone's effects on COVID-19 are unclear and need more research.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.